All Stories

  1. Critically ill patients with community-onset intraabdominal infections: Influence of healthcare exposure on resistance rates and mortality
  2. Invasive fungal infection in crtically ill patients: hurdles and next challenges
  3. Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections
  4. Prevalence of and Risk Factors for Biliary Carriage of Bacteria Showing Worrisome and Unexpected Resistance Traits